The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...

At the closing of each growing season, growers start thinking about the next year, and soil testing is an important part of that planning. The Montana State University Extension Soil Fertility Program ...

A generic drug is a drug that can be manufactured and sold by any company, as long as they meet the stringent criteria for purity as required by Health Canada. It is usually sold under a generic name, ...

The FDA signed off on a second generic option for the abortion pill mifepristone on Tuesday, hours before most of the federal government shut down and despite Republican opposition to the drug. Evita ...

Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...

Aug 28 (Reuters) - The U.S. Food and Drug Administration has approved Teva Pharmaceuticals' (TEVA.TA), opens new tab cheaper generic version of Novo Nordisk's (NOVOb.CO), opens new tab older ...

Teva's generic Saxenda is the first generic GLP-1 indicated for weight loss. Richardsen added, “This is the fifth first-to-market entry of a Teva generic this year and is an important addition to Teva ...

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. Monday, Viatris and Amphastar Pharmaceuticals both said they have received the FDA’s ...

A poker cheat sheet is your shortcut to mastering the game quickly. This guide compiles the most important poker rules, hand rankings, probabilities, and strategic tips into one easy-to-follow ...

Kevin A. Schulman ([email protected]) is a professor of medicine at Stanford University, in Stanford, California. He is a board member and shareholder of Grid Therapeutics (an early stage ...